[Clearance of P32 orthophosphate as a means of evaluation of the therapeutic activity of topical steroids].
D001623:Betamethasone / Q000627:therapeutic use*; D006801:Humans; D010248:Paramethasone / Q000627:therapeutic use*; D010759:Phosphorus Isotopes / Q000378:metabolism*; D011278:Pregnanes / Q000627:therapeutic use*; D012867:Skin / Q000378:metabolism; D012871:Skin Diseases / Q000188:drug therapy*; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*
D010759:Phosphorus Isotopes; D011278:Pregnanes; D001623:Betamethasone; D014222:Triamcinolone Acetonide; D010248:Paramethasone
La clearance del P32 ortofosfato come mezzo di valutazione dell'attivitá terapeutica di steroidi topici.